Sort
50,496 grants matching “lung cancer”
DNA hypermethylation in lung tumors
$476,797Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2020 · CA
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation
$476,715Jin Xie · University Of Georgia · R01 · FY2018 · EB
SOUTHWEST ONCOLOGY GROUP CA-13612
$476,677University Of Arizona · U10 · FY2003 · CA
Skeletal Muscle Atrophy and Dysfunction in Human Cancer
$476,671Michael J Toth · University Of Vermont & St Agric College · R01 · FY2020 · AR
Nanoparticles-mediated combination therapy for breast cancer
$476,617Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Identification of Metabolic Vulnerabilities of Ras-Driven Cancer Cells
$476,594Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2015 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$476,553Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2023 · CA
Dissecting Mechanisms of Metastasis Through Comparative Systems Genetics
$476,541David G Kirsch · Duke University · R01 · FY2010 · CA
Translational Research Training Program in Environmental Health Sciences
$476,501Blanca E Himes · University Of Pennsylvania · T32 · FY2023 · ES
Pathways of PAH activation in human lung cells
$476,475Trevor M. Penning · University Of Pennsylvania · R01 · FY2008 · ES
Targeting the Epigenome for Lung Cancer Therapy
$476,450David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
The role of translation initiation factor eIF5B in lung cancer pathogenesis
$476,420Kathryn Ann O'Donnell · Ut Southwestern Medical Center · R01 · FY2025 · CA
The role of translation initiation factor eIF5B in lung cancer pathogenesis
$476,420Kathryn Ann O'Donnell · Ut Southwestern Medical Center · R01 · FY2023 · CA
Placental Senescence in Peripartum Cardiomyopathy
$476,309Jason David Roh · Massachusetts General Hospital · R01 · FY2023 · HL
Mouse Caging for the OHSU Biomedical Research Building (BRB)
$476,304Kim Elizabeth Saunders · Oregon Health & Science University · G20 · FY2009 · RR
Respiratory and genomic contributions to adaptive/maladaptive hypoxia responses
$476,300Tatum S Simonson · University Of California, San Diego · R01 · FY2021 · HL
Clinical validation of the HD-CTC fluid biopsy in early detection of lung cancer.
$476,289Peter Kuhn · Scripps Research Institute, The · R33 · FY2013 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$476,224Xiang Zhang · Baylor College Of Medicine · R01 · FY2022 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$476,224Xiang Zhang · Baylor College Of Medicine · R01 · FY2023 · CA
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
$476,188Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer
$476,186Elsa R Flores · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Respiratory and genomic contributions to adaptive/maladaptive hypoxia responses
$476,185Tatum S Simonson · University Of California, San Diego · R01 · FY2023 · HL
Respiratory and genomic contributions to adaptive/maladaptive hypoxia responses
$476,185Tatum S Simonson · University Of California, San Diego · R01 · FY2022 · HL
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$476,098Stephen S Hecht · University Of Minnesota · R37 · FY2006 · CA
Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies
$475,993Roy H.l. Pang · Woomera Therapeutics, Inc. · R44 · FY2013 · CA